Oliver Gassmann

Transformation through digital innovation is becoming an imperative for every city. The ‘Smart City’ concept promises to solve the most urgent queries of progressive urbanization in the area of mobility, energy, water supply, security, housing deprivation, and inclusion. Despite the exploitation of existing potential in lighthouse-cities that include Barcelona, London, Munich, Lyon, and Vienna, the less tenacious pursuit of smart city possibilities in the majority of municipalities has resulted in major discrepancies between leading smart cities and those that are less aspirational. Although the necessity of action is frequently recognized, an appropriate path of action remains obscure. Smart Cities: Introducing Digital Innovation to Cities offers answers, with clarifying examples, to questions that have remained unanswered for many cities. The book identifies and addresses the core elements and potential of smart cities, best practice methods and tools to be implemented, as well as how diverse stakeholders might be effectively integrated. Based on perennial international research in the field of smart cities, this book brings together the authors' collective experience in practice-based political, administrative, and economic projects to provide a common framework to guide and engage key stakeholders in the transformation and realization of smart cities.

Pharmaceutical giants have doubled their investments in drug development in the past decade only to see new drug approvals remain constant. This book investigates and highlights a set of proactive strategies aimed at generating sustainable competitive advantage based on value-generating business practices. We focus on three sources of pharmaceutical innovation: new management methods in the drug development pipeline, new technologies as enablers for cutting-edge R&D, and new forms of cooperation and internationalization, such as open innovation in the early phases of R&D. Our findings are illustrated by cases from Europe, the US, and Asia.

Business Innovation is key to the continuing prosperity of firms and to the resolution of environmental and societal grand challenges alike. It has, therefore, become one of the core fields of academic inquiry of our times. It is, however, also an inherently inter-disciplinary subject, inviting contributions from a variety of disciplines. Due to their diverse backgrounds, scholars interested in business innovation frequently lack a "common language" and a shared base of knowledge to integrate their individual contributions effectively. This revised and updated edition starts with the fundamental considerations concerning the role of theories, different types of theories, and different forms of logical reasoning in this field. It goes on present seven different schools of thought about business innovation, before it concluding with the main theories currently used to study business innovation. 'Exploring the Field of Business Innovation' aims at making this domain more accessible to scholars irrespective of their background and career stage, fostering the inter-disciplinary debate, and inspiring researchers to look at this phenomenon from new and different angles.

A strong business model is the bedrock of business success. But all too often we fail to adapt, clinging to outdated business models that are no longer promising the results we need. The Business Model Navigator allow you to innovate, test and implement new business models within your industry. Discover the idea of business model innovation, from structuring the process of innovation of a company’s business model to encouraging outside-the-box thinking. With expert authors, The Business Model Navigator combines learning research with evidence of high practical impact, allowing you to master the transformation journey and lead your business to success.

“A must-read for every innovator and transformator!”- - Franziska Tschudi Sauber, President of the Board, Weidmann Group"Collaborative Advantage is packed with great examples and useful insights into innovating for the future. It is an essential guide for anyone interested in Open Innovation."- - Henry Chesbrough, author of Open Innovation, Professor UC Berkeley“In today’s dynamic markets, companies need to collaborate to have access to all assets and capabilities necessary to out-innovate competitors. However, to collaborate effectively is an organizational capability that needs to be build and nurtured. This book shows how.”- - Claudio Feser, Co-Founder Leadership Practice McKinsey & Company“Transformation is a necessity in the new business environment. Collaborative Advantage outlines how to do it in a sustainable way.”- - Marianne Janik, CEO Microsoft Germany The world is changing faster than ever before. Technological disruptions, AI, digital value chains, new ecosystems, and hyper competition are challenging companies. How can managers keep up with the speed of change? Dominant thinking has centered around the concept of ‘competitive advantage,’ - taught to generations of MBA students. But this is no longer enough. Instead, leaders have to think much more in terms of which networks and partnerships they can leverage in order to create and secure the future of their company. Collaborative advantage is the new imperative for the next decades. In this book, the authors analyze how exceptional leaders have not only survived but thrived in volatility by skillfully orchestrating agile collaborative networks with customers, partners and start-ups. In-depth case studies and personal reflections of these leaders provide you with actionable inspirations for your own practice. Underpinned with cutting edge research, it illustrates how these collaborations can be managed in a data-driven way.

Dieses Buch untersucht und beleuchtet die wichtigsten Herausforderungen, denen sich die pharmazeutische Industrie in einem zunehmend wettbewerbsorientierten Umfeld mit inflationären F&E-Investitionen und verschärftem Kostendruck stellen muss. Die Autoren stellen drei Quellen der pharmazeutischen Innovation vor: neue Managementmethoden in der Arzneimittelentwicklung, neue Technologien als Voraussetzung für Spitzenforschung und -entwicklung und neue Formen der Zusammenarbeit und Internationalisierung, wie z. B. Open Innovation in den frühen Phasen der Forschung und Entwicklung. Neue Modelle und Methoden werden anhand von Fallbeispielen aus Europa, den USA und Asien illustriert. Diese dritte, vollständig überarbeitete Auflage wurde erweitert, um die neuesten Entwicklungen im Bereich der offenen und kollaborativen Innovation, die größere strategische Bedeutung von Risikokapital und Investitionen in der Frühphase sowie die neue Palette an aufkommenden Technologien, die jetzt in der pharmazeutischen Innovation eingesetzt werden, zu berücksichtigen.

Dieses Buch bietet einen Überblick über gängige Konzepte und Bausteine des Patentmanagements. Es wendet sich an Führungskräfte in den Bereichen Innovation, F&E und Patentmanagement sowie an Wissenschaftler und Studierende. Basierend auf der Zusammenarbeit mit bzw. einer Analyse von mehr als 450 technologieintensiven Unternehmen aus Europa, USA, Kanada, China, Japan, Südkorea, Brasilien und Indien liefert es wertvolle Informationen zu den Ausprägungen des Patentmanagements. Die 5. Auflage wurde vollständig überarbeitet, aktualisiert und erweitert.

“A must-read for every innovator and transformator!”- - Franziska Tschudi Sauber, President of the Board, Weidmann Group"Collaborative Advantage is packed with great examples and useful insights into innovating for the future. It is an essential guide for anyone interested in Open Innovation."- - Henry Chesbrough, author of Open Innovation, Professor UC Berkeley“In today’s dynamic markets, companies need to collaborate to have access to all assets and capabilities necessary to out-innovate competitors. However, to collaborate effectively is an organizational capability that needs to be build and nurtured. This book shows how.”- - Claudio Feser, Co-Founder Leadership Practice McKinsey & Company“Transformation is a necessity in the new business environment. Collaborative Advantage outlines how to do it in a sustainable way.”- - Marianne Janik, CEO Microsoft Germany The world is changing faster than ever before. Technological disruptions, AI, digital value chains, new ecosystems, and hyper competition are challenging companies. How can managers keep up with the speed of change? Dominant thinking has centered around the concept of ‘competitive advantage,’ - taught to generations of MBA students. But this is no longer enough. Instead, leaders have to think much more in terms of which networks and partnerships they can leverage in order to create and secure the future of their company. Collaborative advantage is the new imperative for the next decades. In this book, the authors analyze how exceptional leaders have not only survived but thrived in volatility by skillfully orchestrating agile collaborative networks with customers, partners and start-ups. In-depth case studies and personal reflections of these leaders provide you with actionable inspirations for your own practice. Underpinned with cutting edge research, it illustrates how these collaborations can be managed in a data-driven way.

Platform companies like Amazon, Alibaba, Apple or Google dominate today's economy, and eight out of the ten most valuable companies worldwide follow a platform business model. Platform businesses act as digital intermediaries harnessing the power of networks, thereby outperforming traditional asset-heavy companies. Amazon and Alibaba are facilitators of transactions between sellers and buyers Apple connects app developers with app users Google facilitates transactions between ordinary web surfers and advertisers. Every product, service, and retail business has the potential to become a platform business, and The Platform Business Navigator will show you how. With a 5-step framework and 88 different patterns to follow, you can avoid common mistakes and ensure your business strategy works. Suitable for entrepreneurs, executives, product managers, and business leaders, you'll also discover a huge variety of different business case studies. You can also find additional content online including videos, a platform canvas and a white paper to delve deeper.

This book provides an overview of the common concepts and building blocks of patent management. It addresses executives in the areas of innovation, R & D, patent and intellectual property management as well as academics and students.The authors give valuable information on the characteristics of patent and intellectual property management, based on the collaboration with companies and organizations from Europe, China, Japan, Argentina, Brazil, India, Canada and the US.A reference for managers who want to bring information technology innovation with a clear intellectual property strategy to the market. A very readable book. Thomas Landolt, Managing Director, IBMA really comprehensive, all-in book about Patents – strategy, value, management and commercialization. And not forgetting what they are for – foster innovation.Dr. Joerg Thomaier, Head of IP Bayer Group

This book provides an overview of the common concepts and building blocks of patent management. It addresses executives in the areas of innovation, R & D, patent and intellectual property management as well as academics and students.The authors give valuable information on the characteristics of patent and intellectual property management, based on the collaboration with companies and organizations from Europe, China, Japan, Argentina, Brazil, India, Canada and the US.A reference for managers who want to bring information technology innovation with a clear intellectual property strategy to the market. A very readable book. Thomas Landolt, Managing Director, IBMA really comprehensive, all-in book about Patents – strategy, value, management and commercialization. And not forgetting what they are for – foster innovation.Dr. Joerg Thomaier, Head of IP Bayer Group

A strong business model is the bedrock to business success. But all too often we fail to adapt, clinging to outdated business models that are no longer promising the results we need. This new edition builds on the well-known methodology of the first edition to allow you to innovate, test and implement new business models within your industry. Discover the idea of business model innovation, from structuring the process of innovation of a company’s business model to encouraging outside-the-box thinking. With expert authors, The Business Model Navigator combines learning research with evidence of high practical impact, allowing you to master the transformation journey and lead your business to success.

This book investigates and highlights the most critical challenges the pharmaceutical industry faces in an increasingly competitive environment of inflationary R&D investments and tightening cost control pressures. The authors present three sources of pharmaceutical innovation: new management methods in the drug development pipeline; new technologies as enablers for cutting-edge R&D; and new forms of cooperation and internationalization, such as open innovation in the early phases of R&D. New models and methods are illustrated with cases from Europe, the US, and Asia. This third fully revised edition was expanded to reflect the latest updates in open and collaborative innovation, the greater strategic importance of venture capital and early-stage investments, and the new range of emerging technologies now being put to use in pharmaceutical innovation.